SBIR TOPIC 229 A ROBUST AND RIGOROUS PHARMACODYNAMIC ASSAY FOR AKT
Award amount
$149,947Program and phase
SBIR · Phase IAward year
2007Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BIOASSAY SYSTEMS, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NWKBSNNFUFN3
- Solicitation number
- PHS 2007-1
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Not Available
- TOPIC 229: PHASE I ERK DEV. OF MOLECULAR PHARMACODYNAMIC ASSAYS
- TOPIC 229: PHASE I AMPK DEV. OF MOLECULAR PHARMACODYNAMIC ASSAYS
- SBIR TOPIC 229 A ROBUST AND RIGOROUS PHARMACODYNAMIC ASSAY FOR PTP1B
- PRODUCING ERYTHROPOIETIN FROM HUMAN KIDNEY CELLS IN CULTURE.
Research funding history
7 SBIR/STTR records share this UEI (1983–2010). Reported award amounts total $1,705,408. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services